Alembic Pharmaceuticals has received the United States Food and Drug Administration approval. The approval allows them to market Carbamazepine tablets in the US. This medication is a generic version of Tegretol Tablets. Carbamazepine tablets are anticonvulsants. They also treat pain from trigeminal neuralgia. The market size for these tablets is estimated at USD 32 million.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/L6AQlWJ
via IFTTT
No comments:
Post a Comment